SARS-CoV-话题@MedSci

#SARS-CoV#

221篇内容 | 3592人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1938101, encodeId=b871193810141, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=A&R：在未接种疫苗的人群中，细胞因子抑制剂治疗对SARS-CoV-2体液免疫反应的阳性率、血清转化率和持续时间的影响, objectType=article, longId=726444, objectId=581ae26444ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=581ae26444ca, replyNumber=0, likeNumber=75, createdTime=2022-10-02, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=581ae26444ca, moduleTitle=A&R：在未接种疫苗的人群中，细胞因子抑制剂治疗对SARS-CoV-2体液免疫反应的阳性率、血清转化率和持续时间的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=581ae26444ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938079, encodeId=5c3619380e9d4, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=临床研究：氯硝柳胺在SARS-CoV-2病毒清除和症状持续时间方面的有效性, objectType=article, longId=295484, objectId=6b3f295484bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b3f295484bf, replyNumber=0, likeNumber=60, createdTime=2022-12-24, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b3f295484bf, moduleTitle=临床研究：氯硝柳胺在SARS-CoV-2病毒清除和症状持续时间方面的有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b3f295484bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938057, encodeId=d033193805e20, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=JCEM：SARS-CoV-2感染后长期血糖控制不受影响, objectType=article, longId=219653, objectId=d0c6219653a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0c6219653a4, replyNumber=0, likeNumber=66, createdTime=2021-11-09, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0c6219653a4, moduleTitle=JCEM：SARS-CoV-2感染后长期血糖控制不受影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0c6219653a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938068, encodeId=7d3b19380685a, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Eur Heart J：SARS-CoV-2感染后非住院个体的多器官评估, objectType=article, longId=293563, objectId=a23e29356341, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a23e29356341, replyNumber=0, likeNumber=68, createdTime=2022-03-04, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a23e29356341, moduleTitle=Eur Heart J：SARS-CoV-2感染后非住院个体的多器官评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a23e29356341)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938106, encodeId=f4691938106ea, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Lancet rheumatology：免疫介导性炎症性疾病患者使用免疫抑制剂进行第二次和第三次SARS-CoV-2疫苗接种后的体液反应：一项队列研究, objectType=article, longId=728016, objectId=b659e280163b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b659e280163b, replyNumber=0, likeNumber=79, createdTime=2022-10-18, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b659e280163b, moduleTitle=Lancet rheumatology：免疫介导性炎症性疾病患者使用免疫抑制剂进行第二次和第三次SARS-CoV-2疫苗接种后的体液反应：一项队列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b659e280163b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938113, encodeId=40761938113ad, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Circulation：接种COVID-19疫苗和SARS-CoV-2感染后心肌炎的风险, objectType=article, longId=736661, objectId=043be366613f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=043be366613f, replyNumber=0, likeNumber=107, createdTime=2023-03-22, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=043be366613f, moduleTitle=Circulation：接种COVID-19疫苗和SARS-CoV-2感染后心肌炎的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=043be366613f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938055, encodeId=572f193805537, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=JNNP：多发性硬化症患者对SARS-CoV-2 mRNA疫苗的体液免疫, objectType=article, longId=219212, objectId=25c4219212b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25c4219212b0, replyNumber=0, likeNumber=82, createdTime=2021-11-10, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25c4219212b0, moduleTitle=JNNP：多发性硬化症患者对SARS-CoV-2 mRNA疫苗的体液免疫, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25c4219212b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938102, encodeId=d2211938102b8, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=CTI：定量检测SARS-CoV-2感染或疫苗后抗体反应的多重血清学方法的验证和性能, objectType=article, longId=726676, objectId=0a76e26676b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a76e26676b0, replyNumber=0, likeNumber=83, createdTime=2022-09-22, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a76e26676b0, moduleTitle=CTI：定量检测SARS-CoV-2感染或疫苗后抗体反应的多重血清学方法的验证和性能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a76e26676b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938111, encodeId=5e03193811164, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Radiology：胸部CT定量评估急性SARS-CoV-2感染后小气道病变的存在, objectType=article, longId=736015, objectId=712ee3601596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=712ee3601596, replyNumber=0, likeNumber=90, createdTime=2023-07-30, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=712ee3601596, moduleTitle=Radiology：胸部CT定量评估急性SARS-CoV-2感染后小气道病变的存在, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=712ee3601596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938078, encodeId=4e0f19380e883, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=柳叶刀风湿病学：自身免疫疾病患者SARS-CoV-2血清阳性打新冠疫苗效果竟然更好, objectType=article, longId=295367, objectId=a62329536ea8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a62329536ea8, replyNumber=0, likeNumber=85, createdTime=2022-02-10, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a62329536ea8, moduleTitle=柳叶刀风湿病学：自身免疫疾病患者SARS-CoV-2血清阳性打新冠疫苗效果竟然更好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a62329536ea8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938067, encodeId=b0f5193806e9b, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Neurology：4种SARS-CoV-2疫苗接种后脑静脉窦血栓形成风险一览，年轻人群首当其冲, objectType=article, longId=293441, objectId=3943293441b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3943293441b7, replyNumber=0, likeNumber=55, createdTime=2022-09-19, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3943293441b7, moduleTitle=Neurology：4种SARS-CoV-2疫苗接种后脑静脉窦血栓形成风险一览，年轻人群首当其冲, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3943293441b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938107, encodeId=43fe193810e29, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=A&R：B细胞数预测接受利妥昔单抗治疗的患者接种SARS-CoV-2疫苗后的体液和细胞反应, objectType=article, longId=729080, objectId=64cee29080f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64cee29080f1, replyNumber=0, likeNumber=86, createdTime=2023-02-01, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64cee29080f1, moduleTitle=A&R：B细胞数预测接受利妥昔单抗治疗的患者接种SARS-CoV-2疫苗后的体液和细胞反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64cee29080f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938091, encodeId=45cf193809170, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=BMC Nephrol ：SARS-CoV-2感染在双峰年龄分布中增加急性肾损伤的风险, objectType=article, longId=300851, objectId=cf323008514f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf323008514f, replyNumber=0, likeNumber=65, createdTime=2022-03-15, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf323008514f, moduleTitle=BMC Nephrol ：SARS-CoV-2感染在双峰年龄分布中增加急性肾损伤的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf323008514f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938050, encodeId=4bce193805081, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=CMAJ：新型冠状病毒SARS-CoV-2变种相对毒力的评估, objectType=article, longId=218640, objectId=19ee21864047, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19ee21864047, replyNumber=0, likeNumber=59, createdTime=2022-02-13, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19ee21864047, moduleTitle=CMAJ：新型冠状病毒SARS-CoV-2变种相对毒力的评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19ee21864047)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938095, encodeId=d26d19380959f, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=J INTERN MED：SARS-CoV-2阳性和阴性个体1年时症状和功能障碍, objectType=article, longId=301372, objectId=29283013e22c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29283013e22c, replyNumber=0, likeNumber=112, createdTime=2023-02-21, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29283013e22c, moduleTitle=J INTERN MED：SARS-CoV-2阳性和阴性个体1年时症状和功能障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29283013e22c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938042, encodeId=384d19380428a, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=AJKD：血液透析患者对mRNA-1273和BNT162b2 SARS-CoV-2疫苗的体液和细胞反应, objectType=article, longId=218314, objectId=6a932183142b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a932183142b, replyNumber=0, likeNumber=73, createdTime=2022-04-11, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a932183142b, moduleTitle=AJKD：血液透析患者对mRNA-1273和BNT162b2 SARS-CoV-2疫苗的体液和细胞反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a932183142b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938051, encodeId=e515193805113, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=史密斯探测证实，BioFlash可检出空气中的SARS-CoV-2变异株，包括德尔塔和德尔塔+, objectType=article, longId=218656, objectId=6f2121865698, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f2121865698, replyNumber=0, likeNumber=76, createdTime=2022-01-24, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f2121865698, moduleTitle=史密斯探测证实，BioFlash可检出空气中的SARS-CoV-2变异株，包括德尔塔和德尔塔+, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f2121865698)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938084, encodeId=9e93193808478, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=JAMA Netw Open：2020年和2021年加拿大成年人第一和第二波SARS-CoV-2血清阳性率评估, objectType=article, longId=299261, objectId=0602299261db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0602299261db, replyNumber=0, likeNumber=64, createdTime=2022-12-27, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0602299261db, moduleTitle=JAMA Netw Open：2020年和2021年加拿大成年人第一和第二波SARS-CoV-2血清阳性率评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0602299261db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938088, encodeId=85c41938088a2, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Nat Commun:利用流行病学和病毒基因组数据研究SARS-CoV-2在医院内传播的特征, objectType=article, longId=299968, objectId=8614299968d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8614299968d1, replyNumber=0, likeNumber=80, createdTime=2022-11-20, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8614299968d1, moduleTitle=Nat Commun:利用流行病学和病毒基因组数据研究SARS-CoV-2在医院内传播的特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8614299968d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938070, encodeId=d55a19380e008, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=JAMA Intern Med：SARS-CoV-2疫苗接种后免疫功能障碍与COVID-19突破性感染的相关性, objectType=article, longId=293882, objectId=584029388253, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=584029388253, replyNumber=0, likeNumber=65, createdTime=2022-01-25, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=584029388253, moduleTitle=JAMA Intern Med：SARS-CoV-2疫苗接种后免疫功能障碍与COVID-19突破性感染的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=584029388253)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SARS-CoV

2020-05-29

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

A&R：在未接种疫苗的人群中，细胞因子抑制剂治疗对SARS-CoV-2体液免疫反应的阳性率、血清转化率和持续时间的影响

2022-10-02

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

临床研究：氯硝柳胺在SARS-CoV-2病毒清除和症状持续时间方面的有效性

2022-12-24

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

JCEM：SARS-CoV-2感染后长期血糖控制不受影响

2021-11-09

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Eur Heart J：SARS-CoV-2感染后非住院个体的多器官评估

2022-03-04

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Lancet rheumatology：免疫介导性炎症性疾病患者使用免疫抑制剂进行第二次和第三次SARS-CoV-2疫苗接种后的体液反应：一项队列研究

2022-10-18

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Circulation：接种COVID-19疫苗和SARS-CoV-2感染后心肌炎的风险

2023-03-22

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

JNNP：多发性硬化症患者对SARS-CoV-2 mRNA疫苗的体液免疫

2021-11-10

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

CTI：定量检测SARS-CoV-2感染或疫苗后抗体反应的多重血清学方法的验证和性能

2022-09-22

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Radiology：胸部CT定量评估急性SARS-CoV-2感染后小气道病变的存在

2023-07-30

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

柳叶刀风湿病学：自身免疫疾病患者SARS-CoV-2血清阳性打新冠疫苗效果竟然更好

2022-02-10

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Neurology：4种SARS-CoV-2疫苗接种后脑静脉窦血栓形成风险一览，年轻人群首当其冲

2022-09-19

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

A&R：B细胞数预测接受利妥昔单抗治疗的患者接种SARS-CoV-2疫苗后的体液和细胞反应

2023-02-01

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

BMC Nephrol ：SARS-CoV-2感染在双峰年龄分布中增加急性肾损伤的风险

2022-03-15

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

CMAJ：新型冠状病毒SARS-CoV-2变种相对毒力的评估

2022-02-13

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

J INTERN MED：SARS-CoV-2阳性和阴性个体1年时症状和功能障碍

2023-02-21

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

AJKD：血液透析患者对mRNA-1273和BNT162b2 SARS-CoV-2疫苗的体液和细胞反应

2022-04-11

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

史密斯探测证实，BioFlash可检出空气中的SARS-CoV-2变异株，包括德尔塔和德尔塔+

2022-01-24

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

JAMA Netw Open：2020年和2021年加拿大成年人第一和第二波SARS-CoV-2血清阳性率评估

2022-12-27

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Nat Commun:利用流行病学和病毒基因组数据研究SARS-CoV-2在医院内传播的特征

2022-11-20

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

JAMA Intern Med：SARS-CoV-2疫苗接种后免疫功能障碍与COVID-19突破性感染的相关性

2022-01-25

科室
- - 订阅+
  - 更多科室
工具
服务